LINC00668 and non-small cell lung carcinoma: LINC00668 promoted tumorigenesis and progression and indicated poor prognosis in not only breast cancer but also other cancers, such as colorectal cancer, hepatocellular carcinoma and non-small-cell lung cancer [25–28].